Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

NCT00252356 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
468
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi